Publications by authors named "Paul Angulo"

Claim this Profile
S
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
Aldo J Montano-Loza, Paul Angulo, Judith Meza-Junco, Carla M M Prado, Michael B Sawyer

J Cachexia Sarcopenia Muscle· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Paul Angulo, David E Kleiner, Sanne Dam-Larsen, Leon A Adams, Einar S Bjornsson

Gastroenterology· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests.
Jérôme Guéchot, Jérôme Boursier, Victor de Ledinghen, Thierry Poynard, Fabrice Carrat, Paul Angulo

Clin Chem Lab Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right upper-quadrant pain in a patient with drug abuse, secondary syphilis and occult hepatitis B virus.
Cory M Fielding, Paul Angulo

Med Princ Pract· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
Sana Mansoor, Lisa Yerian, Rohit Kohli, Stavra Xanthakos, Paul Angulo

Dig Dis Sci· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.
Paul Angulo, Mariana Verdelho Machado, Anna Mae Diehl

Semin Liver Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards.
Jérôme Boursier, Victor de Ledinghen, Thierry Poynard, Jérôme Guéchot, Fabrice Carrat, Paul Angulo

J Hepatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria

Dig Liver Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive prediction of hepatic steatosis.
Jeremy Cumberledge, Paul Angulo

Am J Gastroenterol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease.
Paul Angulo, Jacob George, Christopher P Day, Ester Vanni, Lee Russell

Clin Gastroenterol Hepatol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic steatosis and steatohepatitis: Are they really two distinct entities?
Cory M Fielding, Paul Angulo

Curr Hepatol Rep· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening the bones in primary biliary cirrhosis.
Paul Angulo

Hepatology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.
Roberto Gedaly, Roberto Galuppo, Yolanda Musgrave, Paul Angulo, Jonathan Hundley

J Surg Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive evaluation of NAFLD.
Laurent Castera, Valérie Vilgrain, Paul Angulo

Nat Rev Gastroenterol Hepatol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
Paul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills

Gastroenterology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for venous thromboembolism in patients with chronic liver disease.
Kelly A Walsh, Daniel A Lewis, Timothy M Clifford, Jonathan C Hundley, Yevgeniya Gokun, Paul Angulo

Ann Pharmacother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.
Flavia D Mendes, Ayako Suzuki, Schuyler O Sanderson, Keith D Lindor, Paul Angulo

Clin Gastroenterol Hepatol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
Roberto Gedaly, Paul Angulo, Jonathan Hundley, Michael F Daily, Changguo Chen

J Surg Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can NASH be diagnosed, graded, and staged noninvasively?
Garfield A Grandison, Paul Angulo

Clin Liver Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Framingham risk score and heart disease in nonalcoholic fatty liver disease.
Sombat Treeprasertsuk, Scott Leverage, Leon A Adams, Keith D Lindor, Jennifer St Sauver, Paul Angulo

Liver Int· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease.
Phunchai Charatcharoenwitthaya, Keith D Lindor, Paul Angulo

Dig Dis Sci· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
Roberto Gedaly, Paul Angulo, Changguo Chen, Kate Townsend Creasy, Brett T Spear

Anticancer Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryoglobulins in nonalcoholic Fatty-liver disease: what is the association?
Benjamin C Bryson, Paul Angulo

Gastroenterol Hepatol (N Y)· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine Liver Metastasis: Transplant as Part of Multimodality Liver-Directed Therapy-Reply.
Roberto Gedaly, Michael F Daily, Daniel L Davenport, Patrick P McHugh, Paul Angulo

Arch Surg· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.
Roberto Gedaly, Michael F Daily, Daniel Davenport, Patrick P McHugh, Alvaro Koch, Paul Angulo

Arch Surg· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis